PURPOSE: Metastatic disease is a leading cause of death for patients with breast cancer, driving the need for new therapies. CT20p is a peptide previously discovered by our group that displays cancer-specific cytotoxicity. To design the optimal therapeutic use of the peptide, we identified the intra...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!